Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients
NCT05158972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 924
Last updated 2023-11-13
Summary
Gathering knowledge on the use of Dymista® in Asian patients who receive Dymista® for the first time in routine clinical practice
Conditions
- Allergic Rhinitis
Interventions
- DRUG
-
Dymista
1 spray per nostril twice daily up to four weeks
Sponsors & Collaborators
-
MEDA Pharma GmbH & Co. KG
collaborator INDUSTRY -
Mylan Inc.
lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-27
- Primary Completion
- 2023-10-24
- Completion
- 2023-10-24
Countries
- Hong Kong
- Malaysia
- Taiwan
- Thailand
Study Locations
More Related Trials
-
Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis
NCT02402465 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
NCT02279563 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
NCT02249663 ·Status: UNKNOWN ·Phase: PHASE3
-
Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray
NCT05146206 ·Status: COMPLETED
-
Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
NCT05234580 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
NCT07168473 ·Status: RECRUITING ·Phase: PHASE3
-
Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
NCT01963741 ·Status: COMPLETED ·Phase: NA
-
A Study in Subjects With Perennial Allergic Rhinitis
NCT00210015 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis
NCT00396409 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
NCT00740792 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis
NCT04088721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
NCT00407927 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Stapokibart Injection in Patients With Allergic Rhinitis
NCT06525597 ·Status: RECRUITING ·Phase: PHASE2
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis
NCT06741787 ·Status: NOT_YET_RECRUITING
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
NCT06180083 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
NCT02565212 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Investigation for ALLERMIST (Long Term)
NCT01420822 ·Status: COMPLETED
-
The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis
NCT05912192 ·Status: COMPLETED ·Phase: NA
-
Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects
NCT07345442 ·Status: COMPLETED ·Phase: PHASE1